Ember Therapeutics is Drug Discovery in United States that focus on primary focus business. They cover business area such as Ember Therapeutics Inc, whose primary focus, related family, bmp, mutant, variant, novel formulation, delivery technology, regenerative medicine, disease modification, osteoarthritis, reversal, insulin resistance, organ fibrosis, chronic kidney disease, Alport Syndrome.
-
Primary Focus
-
302 West 12th Street
Suite 114
New York, NY 10014
United States
Private
Ember Therapeutics Incwhose primary focusrelated familybmpmutantvariantnovel formulationdelivery technologyregenerative medicinedisease modificationosteoarthritisreversalinsulin resistanceorgan fibrosischronic kidney diseaseAlport Syndrome
* We use standard office opening hours in near Ember Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ember Therapeutics is Drug Discovery business from United States that founded in - ( years old in ), Ember Therapeutics business is focusing on Primary Focus.
Ember Therapeutics headquarter office and corporate office address is located in 302 West 12th Street Suite 114 New York, NY 10014 United States.
Ember Therapeutics was founded in United States.
In , Ember Therapeutics is currently focus on primary focus sector.
Above is snippet of Google Trends for "primary focus" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ember Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
